Weekly Docetaxel and Bortezomib as First-Line Treatment for Patients with Hormone-Refractory Prostate Cancer: A Minnie Pearl Cancer Research Network Phase II Trial
Year: 2007
Type: article
Study design: Clinical Trial
Source: Clinical Genitourinary Cancer
Authors: John D. Hainsworth, Anthony A. Meluch, David R. Spigel, John Barton, Lisa Simons, Christina Meng, Bruce Gould, F. Anthony Greco
Institutions: Sarah Cannon, Tennessee Oncology, WellStar Health System
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: Takeda Oncology
OpenAlex ID: W2039355568